Literature DB >> 20417863

Recurrent deletion of 9q34 in adult normal karyotype precursor B-cell acute lymphoblastic leukemia.

Norma J Nowak1, Sheila N J Sait, Amer Zeidan, George Deeb, Dan Gaile, Song Liu, LaurieAnn Ford, Paul K Wallace, Eunice S Wang, Meir Wetzler.   

Abstract

The prognosis of adult normal karyotype (NK) precursor B-cell acute lymphoblastic leukemia (B-ALL) has not improved over the last decade, mainly because separation into distinct molecular subsets has been lacking and no targeted treatments are available. We screened the genome of blasts from 10 adult NK B-ALL patients for novel genomic alterations by array comparative genomic hybridization and verified our results with fluorescent in situ hybridization and gene expression profile with the same probes. The results demonstrate cryptic deletions of 9q34 involving SET, PKN3, NUP188, ABL1, and NUP214 in three of the samples. The smallest deletion resulted in the likely juxtaposition of the SET and NUP214 genes. This aberration has not been described before in adult NK B-ALL. Larger number of samples is warranted to determine the prognostic significance of this cryptic deletion. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20417863      PMCID: PMC2862995          DOI: 10.1016/j.cancergencyto.2010.01.014

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  20 in total

1.  Assembly of microarrays for genome-wide measurement of DNA copy number.

Authors:  A M Snijders; N Nowak; R Segraves; S Blackwood; N Brown; J Conroy; G Hamilton; A K Hindle; B Huey; K Kimura; S Law; K Myambo; J Palmer; B Ylstra; J P Yue; J W Gray; A N Jain; D Pinkel; D G Albertson
Journal:  Nat Genet       Date:  2001-11       Impact factor: 38.330

2.  Identification of a new vertebrate nucleoporin, Nup188, with the use of a novel organelle trap assay.

Authors:  B R Miller; M Powers; M Park; W Fischer; D J Forbes
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

3.  Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia.

Authors:  C Graux; J Cools; C Melotte; H Quentmeier; A Ferrando; R Levine; J R Vermeesch; M Stul; B Dutta; N Boeckx; A Bosly; P Heimann; A Uyttebroeck; N Mentens; R Somers; R A F MacLeod; H G Drexler; A T Look; D G Gilliland; L Michaux; P Vandenberghe; I Wlodarska; Peter Marynen; Anne Hagemeijer
Journal:  Nat Genet       Date:  2004-09-12       Impact factor: 38.330

4.  Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival.

Authors:  Mustafa Benekli; Zheng Xia; Kathleen A Donohue; Laurie A Ford; Lynda A Pixley; Maria R Baer; Heinz Baumann; Meir Wetzler
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

5.  Cryptic chromosome 9q34 deletion generates TAF-Ialpha/CAN and TAF-Ibeta/CAN fusion transcripts in acute myeloid leukemia.

Authors:  Roberto Rosati; Roberta La Starza; Gianluca Barba; Paolo Gorello; Valentina Pierini; Caterina Matteucci; Giovanni Roti; Barbara Crescenzi; Teresa Aloisi; Franco Aversa; Massimo Fabrizio Martelli; Cristina Mecucci
Journal:  Haematologica       Date:  2007-02       Impact factor: 9.941

6.  A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.

Authors:  R A Larson; R K Dodge; C P Burns; E J Lee; R M Stone; P Schulman; D Duggan; F R Davey; R E Sobol; S R Frankel
Journal:  Blood       Date:  1995-04-15       Impact factor: 22.113

7.  High-resolution comparative genomic hybridisation yields a high detection rate of chromosomal aberrations in childhood acute lymphoblastic leukaemia.

Authors:  Tim D Kristensen; Finn Wesenberg; Olafur G Jonsson; Niels T Carlsen; Erik Forestier; Maria Kirchhoff; Claes Lundsteen; Kjeld Schmiegelow
Journal:  Eur J Haematol       Date:  2003-06       Impact factor: 2.997

8.  Characterization of dendritic-like cells derived from t(9;22) acute lymphoblastic leukemia blasts.

Authors:  Jaewoo Lee; Sheila N Sait; Meir Wetzler
Journal:  Int Immunol       Date:  2004-08-09       Impact factor: 4.823

9.  Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia.

Authors:  Charles G Mullighan; Salil Goorha; Ina Radtke; Christopher B Miller; Elaine Coustan-Smith; James D Dalton; Kevin Girtman; Susan Mathew; Jing Ma; Stanley B Pounds; Xiaoping Su; Ching-Hon Pui; Mary V Relling; William E Evans; Sheila A Shurtleff; James R Downing
Journal:  Nature       Date:  2007-04-12       Impact factor: 49.962

10.  SET-NUP214 fusion in acute myeloid leukemia- and T-cell acute lymphoblastic leukemia-derived cell lines.

Authors:  Hilmar Quentmeier; Björn Schneider; Sonja Röhrs; Julia Romani; Margarete Zaborski; Roderick A F Macleod; Hans G Drexler
Journal:  J Hematol Oncol       Date:  2009-01-23       Impact factor: 17.388

View more
  4 in total

1.  SET-CAN Fusion Gene in Acute Leukemia and Myeloid Neoplasms: Report of Three Cases and a Literature Review.

Authors:  Heyang Zhang; Lijun Zhang; Yan Li; Hongcang Gu; Xiaoxue Wang
Journal:  Onco Targets Ther       Date:  2020-08-03       Impact factor: 4.147

2.  A modified form of diphthamide causes immunotoxin resistance in a lymphoma cell line with a deletion of the WDR85 gene.

Authors:  Hui Wei; Tapan K Bera; Alan S Wayne; Laiman Xiang; Simona Colantonio; Oleg Chertov; Ira Pastan
Journal:  J Biol Chem       Date:  2013-03-13       Impact factor: 5.157

3.  [Clinical characteristics of four SET-NUP214 positive acute leukemia patients].

Authors:  X Y Dong; Y L Li; L S Liu; W Cheng; B J Shang; L Zhang; M Y Shi; F Wang; K Sun
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-12-14

4.  The characteristics and prognostic significance of the SET-CAN/NUP214 fusion gene in hematological malignancies: A systematic review.

Authors:  Jing Wang; Qian-Ru Zhan; Xiao-Xuan Lu; Li-Jun Zhang; Xiao-Xue Wang; He-Yang Zhang
Journal:  Medicine (Baltimore)       Date:  2022-07-29       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.